The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, that are also associated with male hypogonadism (MH). Therefore, obesity has been classically identified as the most evident link...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Andrea Graziani, Giuseppe Grande, Alberto Ferlin
Format:	Article
Sprog:	English
Udgivet:	Frontiers Media S.A. 2023-10-01
Serier:	Frontiers in Reproductive Health
Fag:	OSAS hypogonadism testosterone testosterone replacement therapy obesity
Online adgang:	https://www.frontiersin.org/articles/10.3389/frph.2023.1219239/full

Lignende værker

Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
af: Julius Fink, et al.
Udgivet: (2024-02-01)

Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
af: N. I. Volkova, et al.
Udgivet: (2022-09-01)

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism
af: Paolo Facondo, et al.
Udgivet: (2022-12-01)

ASSESSING CARDIOVASCULAR SAFETY OF TESTOSTERONE REPLACEMENT THERAPY FOR MALE HYPOGONADISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
af: Manarul Iman Alfafa Rachman, et al.
Udgivet: (2024-09-01)

Impact of testosterone levels and testosterone replacement ther-apy on men’s health
af: Zuzanna Karbowska, et al.
Udgivet: (2023-12-01)

Acquired Male Hypogonadism in the Post-Genomic Era—A Narrative Review
af: Giuseppe Grande, et al.
Udgivet: (2023-09-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Udgivet: (2012-12-01)

Plasma metabolomics in male primary and functional hypogonadism
af: Giuseppe Grande, et al.
Udgivet: (2023-05-01)

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
af: Giuseppe Lisco, et al.
Udgivet: (2020-10-01)

LATE ONSET HYPOGONADISM: TO TREAT, NOT TO TREAT AND WHO MUST TREAT?
af: Z. R. Gusova, et al.
Udgivet: (2016-03-01)

Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis
af: Rossella Cannarella, et al.
Udgivet: (2024-01-01)

Sleep disorders and testosterone deficiency in men
af: I. A. Khripun, et al.
Udgivet: (2025-01-01)

Evaluation of sexual functional status and consistency of scales in patients with hypogonadotropic hypogonadism before and after testosterone replacement therapy: a single-center experience
af: Umit Aydogan, et al.
Udgivet: (2023-01-01)

Application of Transdermal Testosterone in Treatment of Male Hypogonadism
af: Mahgol Tajbakhsh, et al.
Udgivet: (2018-10-01)

The association of hypogonadism with depression and its treatments
af: Rita Indirli, et al.
Udgivet: (2023-08-01)

Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men
af: Geoffrey Hackett, et al.
Udgivet: (2024-10-01)

Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
af: Ivan I. Dedov, et al.
Udgivet: (2017-12-01)

Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge
af: Kristina Groti Antonič, et al.
Udgivet: (2024-12-01)

The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
af: Michael Zitzmann, et al.
Udgivet: (2022-12-01)

Testosterone replacement therapy in adolescents and young men
af: Alexandra Aponte Varnum, et al.
Udgivet: (2024-10-01)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
af: Maurício de Almeida Ferreira, et al.
Udgivet: (2022-02-01)

A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation
af: Andrew Morton, et al.
Udgivet: (2021-01-01)

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
af: Campbell K, et al.
Udgivet: (2023-03-01)

Syndrome of hypogonadism in males
Udgivet: (2014-06-01)

Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy
af: Robert M. Coward, et al.
Udgivet: (2010-12-01)

Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report
af: Belinda F. Morrison, et al.
Udgivet: (2015-11-01)

Osteoporosis and bone metabolism in patients with Klinefelter syndrome
af: Giuseppe Grande, et al.
Udgivet: (2023-07-01)

Testosterone and aging male, a perspective from a developing country
af: Bac Nguyen Hoai, et al.
Udgivet: (2023-12-01)

Testosterone treatment in the aging male: myth or reality?
af: Nicole Nigro, et al.
Udgivet: (2012-03-01)

Does Testosterone Salvage PDE5i Non-Responders? A Scoping Review
af: Mike Pignanelli, et al.
Udgivet: (2023-02-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
af: Galina Afanas'evna Melnichenko, et al.
Udgivet: (2017-06-01)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
af: Kevin M. Pantalone, et al.
Udgivet: (2019-03-01)

Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
af: María Molina-Vega, et al.
Udgivet: (2018-01-01)

The role of anti-aging approaches in managing hypogonadism in sedentary older males
af: Khaled A. Abdel-Sater
Udgivet: (2024-11-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Udgivet: (2013-03-01)

High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study
af: Amar Osmancevic, et al.
Udgivet: (2022-06-01)

Association of hypogonadism with the severity of chronic obstructive pulmonary disease
af: MA. Zohal, et al.
Udgivet: (2015-12-01)

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus
af: Galina A. Mel'nichenko, et al.
Udgivet: (2019-12-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
af: Galina A. Melnichenko, et al.
Udgivet: (2019-06-01)

Clomiphene citrate treatment for late onset hypogonadism: rise and fall
af: Marcelo Marconi, et al.